Arriving in San Antonio for #AUA24 , the first eminent question is 👉 Do I have the right pairs of shoes 👠👞👟👢with me? Especially as a Bavarian (and #Bavaria is considered the Texas of Germany), living in Philly + visiting #Texas for the first time? Will figure it out…

Prostate cancer SNPs not even significantly associated with mortality in men with prostate cancer auajournals.org/doi/epdf/10.10…

Important work on #PenileCancer micro-environment and for potential personalized treatment
👉first single-cell transcriptomic atlas
➡️TP53 and HPV status stratification indicates CSM differences
👉 authors.elsevier.com/a/1i%7Elg14kpl… Maarten Albersen Oscar Brouwer Laura Elst European Urology

Great editorial Enrique Grande joaquim bellmunt Toni Choueiri, MD
More questions than answers right now how to best define #oligometastatic #BladderCancer
Defined for #ProstateCancer for a while, for OMBC reasonable diagnostic/therapeutic strategies need to be evaluated European Urology

Well done Markus Eckstein Niklas Klümper
👉NECTIN4 amplification could possibly be a predictive biomarker for EV treatment response in mUC #BladderCancer
👉One limitation is the retrospective analysis of samples
➡️Call for continuous biomarker assessment in clinical studies

Sharing this poll from Ashish M. Kamat, MD, MBBS
On #NMIBC
Questions asked in the right way to get some great insights related to the variety of treatments used on #BladderCancer

Targeting cell surface proteins is pivotal for advancing prostate cancer treatment, as it open possibilities for new therapies and precision medicine by Misha Beltran Dana-Farber Dana-Farber_GU Toni Choueiri, MD Emre Yekedüz #prostate #cancer #oncology #Apccc24 Advanced Prostate Cancer Consensus Conference…

Welcome to Lugano🇨🇭for Advanced Prostate Cancer Consensus Conference! Talk about a room with a view! Thanks @SilkeGillessen aurelius omlin for the hospitality! Looking forward to an outstanding program #apccc24

Excellent mini-review
#biomarkers of response to Anti- #NECTIN4 #ADC EV in #BladderCancer
➡️More research needed to identify biomarkers predictive of response to EV treatment (and others) and to identify patients not benefiting from treatment
sciencedirect.com/science/articl… Eur Urol Focus

Sharing our study on disease trajectory among men with HR localized #ProstateCancer treated with RP or RT from the PC database Sweden
▶️10% of men overall died from PC in 10 years post diagnosis
▶️1/3 of men who received secondary ADT died from PC 10 years after ADT
BJU International

Sharing a beyond the abstract UroToday.com on our paper about A US Real-World Study of #Treatment Patterns and Outcomes in Localized or Locally Advanced #ProstateCancer Patients Stephen Freedland, MD Neeraj Agarwal, MD, FASCO Chris Pieczonka #LawrenceKarsh @WJUrol
👉urotoday.com/recent-abstrac…

Countdown to #AUA24 ; looking forward to the
AUA-IBCG Bladder Cancer Forum
Sunday, May 5, 2 - 5 pm

Amer. Urol. Assn. IBCG Janet Kukreja Amanda Myers Bladder Cancer Advocacy Network Andrea Necchi Petros Grivas Roger Li Karima Oualla, MD,MSc Shilpa Gupta Stephen B. Williams, MD, MBA, MS, FACHE Prof Param Mariappan…

Gregory Verhoest It is indeed! Beautiful for #Cycling and everything else

Pleased to share our latest work published in Urologic Oncology focusing on precision medicine in #ProstateCancer

Link 👇
authors.elsevier.com/c/1iwC7_OWv~Zu…

Anis Hamid Christopher Sweeney, MBBS
Peter Mac Research